32.36
Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten
Renaissance Technologies LLC Increases Stake in Sanara MedTech Inc. (NASDAQ:SMTI) - MarketBeat
JPMorgan Chase & Co. Acquires 9,516 Shares of Sanara MedTech Inc. (NASDAQ:SMTI) - MarketBeat
Marshall Wace LLP Takes Position in Sanara MedTech Inc. (NASDAQ:SMTI) - MarketBeat
Sanara MedTech Inc. (NASDAQ:SMTI) Shares Acquired by JPMorgan Chase & Co. - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Renaissance Technologies LLC Grows Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Geode Capital Management LLC Decreases Holdings in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech (NASDAQ:SMTI) shareholder returns have been stellar, earning 154% in 5 years - simplywall.st
Sanara MedTech Inc. Announces Closing of $31.6 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - ACCESS Newswire
Sanara MedTech (NASDAQ:SMTI) Shares Down 2.6%What's Next? - MarketBeat
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025 - The Manila Times
Sanara MedTech Inc. to Report Q1 2025 Financial Results on May 14, 2025 - Nasdaq
Sanara MedTech Earnings Preview: Medical Tech Leader Reveals Q1 2025 Results May 14 - Stock Titan
Sanara MedTech to Present at Investor Showcase - TipRanks
How To Trade (SMTI) - news.stocktradersdaily.com
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - marketscreener.com
Medical Technology Leader Sanara MedTech Unveils Growth Strategy at Major Vegas Investor Event - Stock Titan
Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar? - MSN
Sanara MedTech stock hits 52-week low at $25.9 amid challenges By Investing.com - Investing.com South Africa
Sanara MedTech stock hits 52-week low at $25.9 amid challenges - Investing.com Australia
How to Take Advantage of moves in (SMTI) - news.stocktradersdaily.com
Sanara MedTech Inc. Announces Second Quarter 2021 Results and Business Update - ACCESS Newswire
Q1 EPS Estimates for Sanara MedTech Reduced by HC Wainwright - MarketBeat
Cantor Fitzgerald Predicts Sanara MedTech FY2025 Earnings - MarketBeat
Cantor Fitzgerald Reaffirms Overweight Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2024 Earnings Call Transcript - Insider Monkey
HC Wainwright Reduces Earnings Estimates for Sanara MedTech - Defense World
Bank of New York Mellon Corp Purchases 2,528 Shares of Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech (NASDAQ:SMTI) Releases Quarterly Earnings Results - MarketBeat
FY2025 EPS Estimate for Sanara MedTech Decreased by Analyst - Defense World
Sanara MedTech (NASDAQ:SMTI) Earns Overweight Rating from Cantor Fitzgerald - Defense World
Sanara MedTech targets pilot launch of Tissue Health Plus in Q2 2025 - MSN
Sanara MedTech (NASDAQ:SMTI) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
HC Wainwright Issues Positive Forecast for Sanara MedTech (NASDAQ:SMTI) Stock Price - Defense World
Cantor maintains $46 target on Sanara MedTech stock By Investing.com - Investing.com Canada
Where Sanara MedTech Stands With AnalystsSanara MedTech (NASDAQ:SMTI) - Benzinga
Sanara Medtech Inc (NASDAQ:SMTI) Liquidity Decreases - FXDailyReport.com
Sanara MedTech stock target raised to $51 by H.C. Wainwright - Investing.com UK
Cantor maintains $46 target on Sanara MedTech stock - Investing.com
Sanara MedTech reports net loss of USD 1.7M in Q4 2024 - Medical Buyer
Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Stro - GuruFocus
Sanara MedTech Reports Strong Revenue Growth in 2024 - TipRanks
Sanara MedTech Inc. (SMTI) reports earnings - Quartz
Sanara MedTech Inc Reports Q4 2024 Revenue of $26.3M, Beating Es - GuruFocus
Sanara MedTech Inc (SMTI) Shares Gap Down to $32.1 on Mar 25 - GuruFocus.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):